Friday, October 16, 2009
After the memorial
I have posted new links to an enlarged set of photos of Elizabeth and things she loved as well as some photos of the memorial itself. The latter were taken by my son-in-law Todd McDermott and selected and edited by me.
I want to remind you that anyone who would like to make a contribution in Elizabeth's honor may contribute to the fund created to establish The Elizabeth A. Young Lectureship on Stress and Mood Disorders at the University of Michigan. Donations to the Fund can be sent to MBNI, 205 Zina Pitcher Place, Ann Arbor, MI 48109. Att: R. Freedman.
Saturday, September 12, 2009
Memorial Details
I am planning a slideshow of digital photos of Elizabeth and the things that she loved. If you have photos you would like to contribute to this, please Email me full-resolution versions, since they will be projected on a large screen.
Friday, September 4, 2009
Memorial
Thursday, September 3, 2009
Obituary
Dr. Elizabeth Young, Professor of Psychiatry and Senior Research Professor at the Molecular and Behavioral Neuroscience Institute (MBNI) at the University of Michigan passed away on September 1, 2009 after a yearlong battle with leukemia. She was 59 years old.
Dr. Young was an internationally renowned biological psychiatrist who conducted seminal work on stress biology and its role in severe depression and other mood disorders.
Elizabeth was raised in the Detroit and Chicago area, earned her medical degree from the Ohio State University in 1976, and completed her residency in Psychiatry at the same institution in 1979.
Elizabeth came to the University of Michigan Medical School in July 1979 as a research fellow in the Department of Psychiatry. In 1981 she received a postdoctoral fellowship to work in the laboratories of Drs. Huda Akil and Stanley Watson at the Molecular and Behavioral Neuroscience Institute (MBNI). She went on to join the faculty of the MBNI and Psychiatry where she moved through the ranks to the senior positions she occupied at the time of her death.
Dr. Young was the quintessential translational physician scientist—a role she fashioned for herself before its critical importance was widely appreciated. Early in her career, she conducted fundamental research on the biology of endorphins and on the regulation of the hypothalamo-pituitary-adrenal axis by stress. Simultaneously, she undertook groundbreaking studies on the dysregulation of the stress system in major depression. Elizabeth posited that abnormal responsiveness to stress is not only a consequence of depression but may be part and parcel of the pathophysiology of mood disorders. She was fully aware of the intricacies of the stress system at the molecular, brain circuit, and neuroendocrine levels. Therefore, she realized that there were many points of vulnerability where the system could be disrupted, but also many approaches to resetting its intricate balance. It is because of these unique insights that she spent a significant portion of her career devising novel strategies to challenge the stress system and examine its responses in normal subjects and patients with mood disorders.. She analyzed the stress disruption not only in severe depression but also in related and sometimes co-morbid illnesses, such as anxiety disorders or post-traumatic stress disorder (PTSD). A particular focus of her research was understanding gender differences in mood disorders and uncovering the biological and psychosocial reasons for the increased vulnerability of women to depression and anxiety. Her body of work stands as one of the most systematic and mechanistic analyses of the biology of mood disorders in our field.
But Elizabeth was much more than a talented physician scientist. She was also a loving wife and stepmother, a caring physician, a wonderful collaborator and mentor, an ardent gardener and appreciator of the best that life has to offer, and a devoted friend. During her ordeal, she and her equally remarkable husband, Dr. Peter Hinman, maintained a blog in which they shared their trials and their triumphs with their countless friends and colleagues. Their courage, love, thoughtfulness and generosity towards their friends were inspiring. In knowing her, those of us who love her learned not only how to live well, but also how to die well.
She is survived by her husband Dr. Peter Hinman, her step-daughter Dr. Mira Hinman and two step-granddaughters Annika and Celia McDermott-Hinman.
A ceremony to honor her memory is planned for early October and a Scientific Symposium in the Spring. A Memorial Fund has been created to establish The Elizabeth A. Young Lectureship on Stress and Mood Disorders at the University of Michigan. Donations to the Fund can be sent to MBNI, 205 Zina Pitcher Place, Ann Arbor, MI 48109. Att: R. Freedman.
A longer version of this is available here
Tuesday, September 1, 2009
The end
Monday, August 31, 2009
The end is near
Friday, August 28, 2009
Continuing Downhill
Saturday, August 22, 2009
A difficult week
This is all, of course, a sideshow to the main event of trying to treat the relapsed leukemia. The first part of this proceeded uneventfully -- as expected the anti-survivin drug (which almost universally the staff refer to as "survivin", a logical fallacy painful to my logician soul) had no observable side effects -- well probably not. The troubling point that developed over the period, although it is not thought to be due to the drug, was a big spike in her liver enzymes. There seem to be no good theories what caused this, but it was bad enough yesterday that the planned start of the chemotherapy sequence was put on hold. Fortunately (one of the few bits of good news this week) they were down substantially today and they have as I write started the chemotherapy. We have now to hope that the liver problems stay fixed at least long enough to complete the 3 days of chemo.
Tuesday, August 18, 2009
Admission
Sunday, August 16, 2009
Another way forward
After consultation with the hematologist Harry Erba that we saw at the beginning of this process, Elizabeth (with my full agreement) has decided to undertake another round of chemotherapy. This will involve two of the same agents she received in the first two rounds, idarubicin and cytarabine, but also a brand new experimental drug. The experimental drug is intended to reduce the ability of the leukemia cells to develop resistance to being killed by the chemo, a common problem in the treatment of recurring leukemia. There is essentially no data on this drug -- this is a phase 2 clinical trial -- but there seems to be little risk and it might do some good. The chemo portion is the standard chemo they would use for relapsed AML. Depending on the outcome of the chemo we will then decide where to go from there. It is still possible that she might get a second transplant preceded by a less rigorous and more survivable conditioning, but the more we read from the literature it seems that there is little evidence that second transplants are successful.
The chemo must be done as an inpatient, so she will probably be admitted to the hospital again early next week. The predicted stay is 3-4 weeks, but of course it all depends on how things go. Because of the presence of the transplanted donor cells, with the accompanying graft-versus-host disease, chemo at this stage is considerably different from the earlier ones and perhaps less predictable. She is already showing quite noticeable effects of graft vs host disease, which means the donor cells should attack the leukemic cells along with the chemotherapy.
Note that I have changed the photo link at the top right -- in place of just a couple of albums, I now have a link to a new gallery with many of my photos from the past several years. If you have some browsing time, have a look.
Monday, August 10, 2009
A Major Setback
Friday, July 31, 2009
Home again
Tuesday, July 28, 2009
A little longer
We are coming to understand (at least I am) that the back problems are part of a larger syndrome of general muscle weakening brought on by the high-dose steroid treatments. The physical therapy people she has been seeing believe that the support muscles in the back have been so weakened that they don't support her back properly. Furthermore, she seems very weak all over and this is a standard result of steroid treatment. So the therapy is exercise to build the muscles back up. This will probably take a long time, but at least we have a direction. But it leaves her feeling much less well than she really is otherwise.
Saturday, July 25, 2009
Some progress
Thursday, July 16, 2009
Hospital rules
Monday, July 13, 2009
Hospital Round Five
It is often said of this (and other) diseases that the treatment is as bad as the disease. But the chain of effects we have been seeing is quite amazing. Consider the following analysis.
1. Leukemia develops and is treated with chemotherapy. This destroys the cancerous cells, but also the rest of the bone marrow and along with it its products: red cells, white cells and platelets. These losses require transfusions of red cells and platelets and antibiotics to replace the defensive action of the white cells.
2. A marrow transplant is the permanent solution to the marrow destruction. However, the new marrow sees the rest of the body and "foreign" and thus requires
3. treatment with immuno-suppressive agents, milder at first, but eventually steroids to suppress specific attacks. The new marrow pumps out all three types of cells, but the immuno-suppressants prevent the white cells from acting effectively (which they need to do) and thus permits other infective agents, such as CMV, which is present in most humans, to grow uncontrolled.
4. Anti-viral agents are then used to control the CMV, but these in turn have destructive effects as mentioned above on electrolytes and kidney function and also in suppressing the actual production of all three types of cells.
5. These effects must then be treated in various ways with direct IV administration of electrolytes; the kidney problems have yet to develop, so I don't know what that might entail.
So at this point we are monitoring and treating fifth-order side effects -- how far can this go?
Wednesday, July 1, 2009
Very positive overall with speed bumps
Her gut is making a steady recovery with a much improved appetite and the ability to tolerate a steadily growing list of foods. She still has considerable edema from the steroids (which are still being administered at reduced doses). The worst current problem may or may not have much to do with everything else -- she is suffering from quite bad lower back pain, enough to make it hard for her to get around and impossible to get the exercise that she needs to strengthen her leg muscles. One theory is that this was brought on by a brief period just after the hospital stay when she was getting IV nutrition in a 1.5 liter bag that she had to carry around, together with a pump, in a backpack. But since it's a problem she has had before, it may also be coincidence that it is showing up now. She is continuing to get the ECP treatments twice a week, various shots, weekly clinic visits, other tests, and frequent blood draws -- we seem to have some sort of appointment every weekday (often including lengthy stays in waiting rooms) and sometimes more than one. It does occupy a good part of our time.
Thursday, June 25, 2009
Bayeux Tapestry
Those of you who have visited Elizabeth either at home or in the hospital have no doubt seen stages of this creation. It is an embroidery kit based on a segment of the Bayeux Tapestry -- in this case the very first panel in which Edward sends Harold off to France to tell William that he is to be the next King of England -- check out the Wikipedia entry for more. We bought the kit in 2001 on a visit to Bayeux where there is a marvelous museum housing the tapestry. Elizabeth always thought of it as a retirement project, but it has been ideal for this period when she has a lot of time on her hands. In fact, as she was nearing the completion of this segment, I ordered online two more from the museum; she is already nearly finished with the first of these. This one is about 26 x 17 inches, the others are bigger.
Monday, June 22, 2009
Home again
Wednesday, June 17, 2009
Amazing treatment
Saturday, June 13, 2009
Contact info
Friday, June 12, 2009
Back to the hospital
Sunday, June 7, 2009
Update
Valcyte also depresses blood levels of red and white cells and platelets, so we hope and expect that these will improve in its absence -- reds and platelets are doing reasonably well, but whites have been dropping to the point that she was officially neutropenic (ANC below 1.0) at the end of last week. Also a few shots of Neupogen have been authorized and should boost the neutrophil count. Today is day 81, nearing the watershed day 100. One of the immunosuppressants, CellCept, as already been reduced to 2/3 dose, and we expect that soon also Tacrolimus will be cut back, so perhaps this will also reduce the side effects.
Tuesday, May 19, 2009
Life goes on
Wednesday, May 13, 2009
Update
Elizabeth
Wednesday, May 6, 2009
It's a long haul
Tuesday, April 21, 2009
Great News!
Monday, April 13, 2009
Doing better again
To deal with my quezy stomach which diminished my appetite they gave me regular Zofran which has helped my appetite now. And most of the “funny taste” with my food is gone.
Elizabeth
Thursday, April 9, 2009
Not perfect, but it could be worse
Monday, March 30, 2009
Home!
Saturday, March 28, 2009
Day +10
engraftment. They are talking about discharge early next week. The new
Doctor, John Levine, says there is about a 50% chance I will need
re-hospitalization in the next month but we think this sounds very good.
Better to be home than sitting here
Elizabeth
Friday, March 27, 2009
So far so good
Thursday, March 19, 2009
Transplant accomplished



The transplant finally happened about 9 PM yesterday. The cells arrived at Metro airport (we don't know where from) around 5 PM and were taken to the hospital blood unit for various procedures. Among the most interesting things, they do a count of the actual cells. The sending organization reported about 9 million cells, which our docs evaluated as way too many. They were aiming for 4-4.5 million, so initially they divided the sample and gave her one half. Overnight they did their own count, which agreed closely (which apparently doesn't always happen) and now estimate that she got 4.45 million cells. The goal is to have enough cells to initiate just enough GVHD (graft versus host disease, an immune system reaction) to knock out any remaining leukemic cells in her body without triggering destructive GVHD that might attack other organs -- liver, kidney, lung, even brain. The full 9 million would have overwhelmed her body and probably done a lot of damage. They can and do freeze the remaining cells for later use. Since each case is different, it sometimes happens that the initial dose is not enough to kill the leukemic cells, in which case they pump in some more at a later date. All very amazing.
The actual infusion was a bit anticlimactic -- it is just like a blood transfusion, only shorter. It took about 45 minutes, longer than I have heard from others who have done this. The attending on the unit -- Greg Yannik -- did the whole thing, for the most part without even a nurse present. This seemed surprising, since all of the blood and platelet transfusions have been done entirely by nurses. Still, it was an exciting moment, with luck the process that will really cure Elizabeth and get her back to good health.
Saturday, March 14, 2009
All is well so far
Thursday, March 12, 2009
Towards the transplant
She is again on the 8A unit, which is where all the BMT patients stay whenever possible. Her phone is 734-936-8408, and for now she is happy to get calls, although as usual there are times when she is not in a position to answer the phone. She has a very nice room, one that is set up as a double, but is being used as a single, so there is much more room and it doesn't feel nearly so cramped. We call it her suite.
The chemo regimen starts tomorrow morning and runs Friday-Monday. Tuesday is free and the transplant is scheduled for Wednesday. As far as we know, the actual infusion of stem cells will not be any more taxing than a standard blood transfusion, of which she has had many. Of course, it is expected to have many more effects, both positive and negative, than a transfusion.
Tuesday, March 3, 2009
More schedule
Friday, February 27, 2009
New schedule
Saturday, February 21, 2009
The next few weeks
We met with the BMT (bone marrow transplant) team on Friday. The original plan was for her to be admitted around now for the transplant, but things haven't been finalized with the donor and in any case they want her to have recovered more thoroughly to be strong going in to the process. On the other hand, they don't want to delay too long to risk that the leukemia might return -- it is considered important that she be in complete remission at the start of the transplant process. So the current thinking is that she will be admitted around March 19 for the transplant. At that point she will be in the hospital for at least a month and in a rather delicate state for the first 100 days after the transplant.
If she can get to a state of not needing transfusions so frequently, we are hoping to be able to get away for a few days in March to someplace warm and fun -- we'll see if it works out.
Monday, February 9, 2009
Home again!
Monday, February 2, 2009
Soup alert
I take them in a thermos that holds 2 cups and serves both of us. We have lots of freezer containers, so feel free to bring a large container for me to divide up. They can be left on our front porch while the weather is still cold. While I am away Wednesday evening-Sunday afternoon my daughter Mira will be in town to be with Elizabeth and can put them away.